Oncimmune Share Discussion Threads

[brummy_git] 20/9/2021 07:32

More marvellous contract news from Oncimmune - a pioneering immunodiagnostics firm. All the commentary here. www.linkedin.com/posts/paul-hill-a5994116_onc-immunoinsights-activity-6845604965579325440-_YDA

[coalfired] 15/9/2021 21:00

Spread is showing as 180-190. At close I could buy 183 and sell 181.5. Lunchtime the bid was higher than the ask. The MM's do play around with this one.

[trotterstrading] 15/9/2021 15:09

News soon IMHO

[coalfired] 11/8/2021 14:41

Well something is bubbling, it's creeping up slowly on small sells, usually a good sign for a leg up.

[trotterstrading] 11/8/2021 09:26

Tick tock - just a few weeks of the Q1 '22 reporting period, where the CEO highlighted strong deal flow expected during this period in the last trading update.

[brummy_git] 30/7/2021 15:14

Oncimmune was discussed here on today's Vox 'Stock Picking' videocast (starts 51:20). www.linkedin.com/posts/paul-hill-a5994116_stocks-to-follow-with-justin-waite-and-paul-activity-6826865195483242496-ww3t

[trotterstrading] 23/7/2021 07:24

Another brilliant RNS! This company is seriously going places

[trotterstrading] 21/7/2021 12:54

And a few more at £1.60! Looking for £3 a share in 6-12 months

[trotterstrading] 16/7/2021 16:57

Took a few more on the drop today, happy to accumulate while it's quiet

[trotterstrading] 06/7/2021 11:57

Someone's is keen, some nice lumps coming in

[trotterstrading] 05/7/2021 08:11

Looks like a seller held us back last week.. news due now

[hatfullofsky] 01/7/2021 21:24

Now below the placing price

[hatfullofsky] 01/7/2021 15:33

Well this is frustrating

[trotterstrading] 28/6/2021 09:43

Added again at 180 odd. News on many fronts due

[trotterstrading] 21/6/2021 09:11

I feel another top up coming on, cheap!

[homebrewruss] 09/6/2021 09:10

Recording and Q&A now available from yesterday hTTps://www.investormeetcompany.com/investor/meeting/fy2021-end-of-year-trading-update

[pugugly] 08/6/2021 17:13

IMC Useful presentation with useful revene figures - Has been recorded and well worth a listen (imo) if a holder or a potential investor

[trotterstrading] 08/6/2021 15:21

Clear takeover target. Premium offer coming soon IMHO

[homebrewruss] 08/6/2021 11:48

Latest proactive interview hTTps://www.youtube.com/watch?v=ManVu25RJ2w&ab_channel=Proactive and ONC also presenting on investor meet later today at 4.30pm hTTps://www.investormeetcompany.com/oncimmune-holdings-plc/register-investor

[someuwin] 08/6/2021 11:13

N+1 Singer Trading update reaffirms positive outlook A comprehensive FY’21 (May Y/E) trading statement touts a strong FY’21 outturn in line with our expectations that shows 8x topline growth, building strength in the ImmunoINSIGHTS service business and sets the tone for future upgrades. We leave estimates unchanged, but believe forecasts are prudently pitched with risk to the upside. Notably Investors should take confidence in that management believes that, eight days into the new financial year and a strong start to FY’22, it has visibility on up to 50% of our current FY’22 ImmunoINSIGHTS revenue estimate (£9.4m) and has used today’s statement to reiterate confidence in meeting expectations and delivering maiden profitability in FY’22. Refreshing our valuation analysis implies an intrinsic value of 271p, we reiterate Oncimmune as a Best Idea for 2021...

[trotterstrading] 08/6/2021 08:15

Huge growth story unfolding here, I'm expecting 100% share price growth from here within 12 months

[waterloo01] 08/6/2021 07:15

Agree positive update and good to see NHS work picking up.

[someuwin] 08/6/2021 07:13

Trading Update. All looks v positive to me. New contracts to be signed before end August... "The ImmunoINSIGHTS pipeline of qualified commercial opportunities has continued to grow throughout FY21 and currently stands at more than 160. A number of these opportunities are in late stage legal documentation and, as a consequence, the Company expects to sign these new contracts in Q1 FY22. These studies have been programmed into the Company's forward production schedule, which entails identifying and assigning the resources required to deliver each contract. Of particular note in this schedule are two contracts for major pharmaceutical companies which represent substantial follow-on validation contracts."